First Tracks Biotherapeutics, Inc. (TRAX)

NASDAQ: TRAX · Real-Time Price · USD

47.90

+2.47 (5.44%)

At close: Nov 6, 2026, 4:00 PM EST

47.00

-0.90 (-1.88%)

After-hours: Nov 6, 2026, 7:56 PM EST

TRAX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	155.63	238.2	123.08	35.97
Short-Term Investments	-	73.44	262.29	354.94
Cash & Short-Term Investments	155.63	311.64	385.37	390.9
Cash Growth	-	-19.13%	-1.42%	-
Prepaid Expenses	5.22	4.76	4.56	7.65
Total Current Assets	165.72	316.4	389.93	398.56
Property, Plant & Equipment	4.73	13.89	16.23	18.27
Long-Term Investments	-	-	35.47	27.03
Other Long-Term Assets	-	0.26	0.26	0.26
Total Assets	170.46	330.55	441.89	444.11

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accounts Payable	3.95	3.11	3.79	2.43
Accrued Expenses	11.72	25.83	30.47	14.02
Current Portion of Leases	2.42	2.08	1.93	1.78
Total Current Liabilities	18.09	31.02	36.18	18.22
Long-Term Leases	1.36	12.03	14.11	16.04
Total Liabilities	19.45	43.06	50.3	34.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Common Stock	0.04	287.51	391.29	410.65
Comprehensive Income & Other	-	-0.02	0.31	-0.8
Shareholders' Equity	151.01	287.49	391.6	409.85
Total Liabilities & Equity	170.46	330.55	441.89	444.11

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Total Debt	3.77	14.11	16.04	17.81
Net Cash (Debt)	151.85	297.53	369.34	373.09
Net Cash Growth	-	-19.44%	-1.01%	-
Working Capital	147.63	285.38	353.75	380.33
Tangible Book Value	151.01	287.49	391.6	409.85
Machinery	8.35	8.31	8.25	8.11
Leasehold Improvements	-	0.2	0.2	0.2